Diagnosis And Treatment

Study finds stroke risk from anemia drug Aranesp
A new study raises fresh safety concerns about widely used anemia medicines, finding that the drug Aranesp nearly doubled the risk of stroke in people with diabetes and chronic kidney problems who are not yet sick enough to need dialysis.

TRENTON, N.J. - Drugmaker Bristol-Myers Squibb Co.

WORCESTER, Mass. - Generex Biotechnology Corp.
Older News
S M T W T F S
24 25 26 27 28 29 30
31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
Copyright© 2010 The Gaea Times